Pertussis in infants, children, and adolescents: diagnosis, treatment, and prevention

FM Munoz - Seminars in pediatric infectious diseases, 2006 - Elsevier
Pertussis, or “whooping cough,” caused by the gram-negative pleomorphic bacillus
Bordetella pertussis, is a highly contagious, potentially life-threatening respiratory tract …

Benefits of combination vaccines: effective vaccination on a simplified schedule.

D Dodd - The American journal of managed care, 2003 - europepmc.org
BACKGROUND: The number of recommended immunizations during childhood has
increased significantly over the years. Today, infants receive vaccines against 11 diseases …

Does antigenic overload exist? The role of multiple immunizations in infants

AL Gregson, R Edelman - Immunology and Allergy …, 2003 - immunology.theclinics.com
Background Simultaneous administration of multiple vaccines to infants and children is
becoming routine. The large number of recommended childhood vaccines necessitates …

Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants

MOC Ota, AA Odutola, PK Owiafe, S Donkor… - Science translational …, 2011 - science.org
New tuberculosis vaccines are urgently needed to curtail the current epidemic. MVA85A is a
subunit vaccine that could enhance immunity from BCG vaccination. To determine MVA85A …

Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7 …

ME Pichichero, H Bernstein, MM Blatter… - The Journal of …, 2007 - Elsevier
OBJECTIVE: To evaluate the immunogenicity and safety of a diphtheria and tetanus toxoids,
acellular pertussis, hepatitis B, and inactivated poliovirus-containing vaccine (DTaP-HepB …

Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and …

F Zepp, M Knuf, U Heininger, K Jahn, A Collard… - Vaccine, 2004 - Elsevier
Safety, reactogenicity and immunogenicity of GSK Biologicals' hexavalent DTPa–HBV–
IPV/Hib vaccine (Infanrix® hexa) was assessed when used for primary vaccination at 3, 4 …

Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b …

U Heininger, DTPHBV The, R Sänger, JM Jacquet… - Vaccine, 2007 - Elsevier
The immunogenicity and reactogenicity of booster vaccination with GSK Biologicals'
hexavalent DTPa-HBV-IPV/Hib vaccine was assessed in toddlers aged 12–18 months …

A randomized, open label trial to evaluate and compare the immunogenicity and safety of a novel liquid hexavalent DTwP-Hib/Hep B-IPV (EasySix™) to licensed …

L Mohanty, S Sharma, B Behera, S Panwar, C Paliwal… - Vaccine, 2018 - Elsevier
Immunogenicity and safety of a newly developed liquid DTwP-Hib/HepB-IPV hexavalent
vaccine (EasySix™) was evaluated and compared with administration of commercially …

Evaluation of the immunogenicity and reactogenicity of a DTPa-HBV-IPV combination vaccine co-administered with a Hib conjugate vaccine either as a single …

G Gabutti, F Zepp, L Schuerman, P Dentico… - … journal of infectious …, 2004 - Taylor & Francis
A combined DTPa-HBV-IPV/Hib vaccine containing diphtheria (D), tetanus (T), acellular
pertussis (Pa), hepatitis B (HBV) and types 1, 2 and 3 inactivated polioviruses (IPV) …

A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a …

KM Zangwill, E Eriksen, M Lee, J Lee, SM Marcy… - …, 2008 - publications.aap.org
BACKGROUND. Prelicensure studies of diphtheria, tetanus, acellular pertussis, hepatitis B,
inactivated polio virus vaccine suggested that there were higher rates of fever after its …